New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
07:46 EDTAVNR, IPXLAvanir likely win patent case against Impax, says Jefferies
After reviewing court transcripts, Jefferies believes Avanir (AVNR) is likely to win its Nuedexta patent trial against Impax (IPXL). The firm says that while the stock is may rally on the patent win, it sees limited upside and keeps a Hold rating on Avanir. Jefferies notes that its $4 price target already assumes full credit for the Nuedexta patent.
News For AVNR;IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
10:35 EDTIPXLHigh option volume stocks
Subscribe for More Information
06:26 EDTAVNRAvanir 18.2M share Secondary priced at $11.00
Subscribe for More Information
September 23, 2014
06:12 EDTAVNRStocks with implied volatility below IV index mean; RAX AVNR
Subscribe for More Information
September 22, 2014
18:18 EDTAVNROn The Fly: After Hours Movers
Subscribe for More Information
16:41 EDTAVNRAvanir files automatic mixed securities shelf
11:02 EDTAVNROptions with decreasing implied volatility
Subscribe for More Information
06:17 EDTAVNRAvanir implied volatility of 91 at lower end of index mean range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use